Sign inJoin waitlistJoin the waitlist

Kristen Marrone

Program Director · Johns Hopkins University School of Medicine

Credentials: · · · ·

History

Johns Hopkins University School of Medicine
Present

Medical Oncology
2014–2016
Internal Medicine
2011–2014
Doctor of Medicine
2007–2011

Research

Neoadjuvant PD-1 Blockade in Resectable Lung Cancer
New England Journal of Medicine · 2018 · 1,667 citations
Genome-wide cell-free DNA fragmentation in patients with cancer
Nature · 2019 · 1,117 citations
Clinicopathological features of acute kidney injury associated with immune checkpoint inhibitors
Kidney International · 2016 · 494 citations

Julie Brahmer
48 papers
PF
Patrick Forde
44 papers
JN
Jarushka Naidoo
30 papers
JF
Josephine Feliciano
28 papers
CH
Christine Hann
27 papers
Valsamo Anagnostou
27 papers
BL
Benjamin Levy
24 papers
VL
Vincent Lam
22 papers
DE
David Ettinger
20 papers
JM
Joseph Murray
17 papers · 1 as a fellow
SS
Susan Scott
13 papers · 2 as a fellow
Ranh Voong
11 papers

Clinical trials

Neoadjuvant KRAS G12C Directed Therapy With Adagrasib (MRTX849) With or Without Nivolumab
Principal investigator · Withdrawn · Phase 2
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
2023–2025
KRAS-Targeted Vaccine With Chemoimmunotherapy, Nivolumab and Ipilimumab for Patients With NSCLC
Principal investigator · Recruiting · Phase 1
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
2022–2027
Study of Olomorasib (LY3537982) in Combination With Standard of Care in Participants With Resected or Unresectable KRAS G12C-mutant Non-Small Cell Lung Cancer
Site PI · Recruiting · Phase 3
Eli Lilly and Company
2025–2032
A Study of First-Line Olomorasib (LY3537982) and Pembrolizumab With or Without Chemotherapy in Patients With Advanced KRAS G12C-Mutant Non-small Cell Lung Cancer
Site PI · Recruiting · Phase 3
Eli Lilly and Company
2023–2031